| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.0009 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.19 | 0.001 |